ArticlesDownstreamRegulatoryUpstream July 16, 2020 Eliminating Residual Impurities Starts with a Strategic Plan Residual impurity testing is essential to ensure the quality and safety of pharmaceutical products... admin-element
DownstreamQ&A July 16, 2020 Next Generation Process Chromatography Chromatography is an essential part in the production of all biopharmaceuticals. Without it the... admin-element
Articles July 2, 2020 Step Up to GMP Manufacturing or Outsource to a CDMO: Considerations and Tips Whether you are developing a new monoclonal antibody (mAb), cell therapy, gene therapy, or... admin-element
ArticlesBioPharmaDownstreamRegulatoryUpstream June 4, 2020 Biomanufacturing: Demand for Continuous Bioprocessing Increasing In nearly all other manufacturing technologies, cost considerations dictate that... admin-element
ArticlesBioPharmaDownstreamRegulatoryUpstream May 21, 2020 Gene Therapies Push Viral Vector Production Several virus types have been studied for use as viral vectors in gene therapy, including… admin-element
ArticlesBioPharmaRegulatory March 26, 2020 Can Vaccine Development Be Safely Accelerated? Human coronaviruses (HCoVs) in the past were considered to cause nothing more than the... admin-element
Articles March 26, 2020 Manufacturing of Vaccines and Viral Vectors With the pandemic outbreak of COVID-19, there is intense focus on developing a vaccine. However,… admin-element
ArticlesDownstreamUpstream March 12, 2020 Improving Upstream Predictability In the earliest days of biotech, developers often struggled to sustain conditions that would... admin-element
Articles March 12, 2020 Getting Ahead of the Game in Cell and Gene Therapy Successes in the clinic have placed many cell and gene therapies on an accelerated route… admin-element
ArticlesDownstreamUpstream March 12, 2020 Flexible Facilities for Viral Vector Manufacturing Industry experts have noted that there are limitations in the number of scalable... admin-element